Breast cancer prognosis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Lymph Nodes Nipples Neoplastic Stem Cells Neoplastic Cells, Circulating Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases47

Breast Neoplasms Lymphatic Metastasis Neoplasm Recurrence, Local Carcinoma, Ductal, Breast Neoplasm Invasiveness Breast Diseases Neoplasm Metastasis Neoplasms Lung Neoplasms Ovarian Neoplasms Carcinoma Breast Neoplasms, Male Disease Progression Prostatic Neoplasms Adenocarcinoma Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Colorectal Neoplasms Colonic Neoplasms Neoplasms, Hormone-Dependent Mammary Neoplasms, Experimental Fibrocystic Breast Disease Bone Neoplasms Stomach Neoplasms Carcinoma, Ductal Cell Transformation, Neoplastic Carcinoma in Situ Neoplasms, Second Primary Triple Negative Breast Neoplasms Pancreatic Neoplasms Inflammatory Breast Neoplasms Neovascularization, Pathologic Neoplastic Cells, Circulating Carcinoma, Squamous Cell Uterine Cervical Neoplasms Fibroadenoma Neoplasms, Basal Cell Carcinoma, Non-Small-Cell Lung Endometrial Neoplasms Liver Neoplasms Neoplasms, Multiple Primary Neoplasms, Radiation-Induced Mammary Neoplasms, Animal Urinary Bladder Neoplasms Pregnancy Complications, Neoplastic Esophageal Neoplasms

Chemicals and Drugs55

Tumor Markers, Biological Receptors, Estrogen Receptors, Progesterone Receptor, erbB-2 Tamoxifen Receptor, Fibroblast Growth Factor, Type 4 Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Estrogen Receptor alpha Estrogens RNA, Messenger BRCA2 Protein BRCA1 Protein Aromatase Inhibitors Estrogen Antagonists DNA, Neoplasm RNA, Small Interfering Fluorouracil Estradiol Cyclophosphamide Antibodies, Monoclonal, Humanized Tumor Suppressor Protein p53 Estrogen Receptor Modulators Epirubicin Selective Estrogen Receptor Modulators Ki-67 Antigen Antibodies, Monoclonal Nitriles Receptor, Epidermal Growth Factor Tumor Suppressor Proteins Antigens, Neoplasm RNA, Neoplasm Paclitaxel Cancer Vaccines Mucin-1 Antigens, CD24 Transcription Factors Anticarcinogenic Agents MicroRNAs Triazoles Anthracyclines DNA-Binding Proteins Antibiotics, Antineoplastic Doxorubicin Proto-Oncogene Proteins c-akt Proto-Oncogene Proteins Nuclear Proteins Cyclin D1 Cisplatin Methotrexate Cadherins Deoxycytidine Progestins Protein-Serine-Threonine Kinases

Analytical, Diagnostic and Therapeutic Techniques and Equipment76

Prognosis Gene Expression Profiling Neoplasm Staging Survival Analysis Survival Rate Disease-Free Survival Follow-Up Studies Proportional Hazards Models Cohort Studies Prospective Studies Risk Factors Mammography Oligonucleotide Array Sequence Analysis Immunohistochemistry Kaplan-Meier Estimate Case-Control Studies Tissue Array Analysis Retrospective Studies Treatment Outcome Mastectomy Early Detection of Cancer Reverse Transcriptase Polymerase Chain Reaction Chemotherapy, Adjuvant Predictive Value of Tests Multivariate Analysis Antineoplastic Combined Chemotherapy Protocols Risk Mammary Neoplasms, Experimental Breast Self-Examination Risk Assessment Incidence Odds Ratio Mastectomy, Segmental Blotting, Western Xenograft Model Antitumor Assays Registries Sensitivity and Specificity Models, Statistical ROC Curve Combined Modality Therapy Neoplasm Transplantation Transplantation, Heterologous Neoplasm Grading Ultrasonography, Mammary Tumor Burden Logistic Models Questionnaires SEER Program Immunoenzyme Techniques Reproducibility of Results Breast Implants Polymerase Chain Reaction Radiotherapy, Adjuvant Transfection Mass Screening Confidence Intervals Clinical Trials as Topic Neoadjuvant Therapy Mammaplasty Biopsy Molecular Targeted Therapy Genetic Testing Biopsy, Needle Radiotherapy Lymph Node Excision In Situ Hybridization, Fluorescence Drug Administration Schedule Drug Screening Assays, Antitumor Gene Knockdown Techniques Sentinel Lymph Node Biopsy Estrogen Replacement Therapy DNA Mutational Analysis Models, Biological Mastectomy, Radical Real-Time Polymerase Chain Reaction Chi-Square Distribution

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes53

Gene Expression Regulation, Neoplastic Genes, BRCA1 Postmenopause Time Factors Genetic Predisposition to Disease Drug Resistance, Neoplasm Breast Feeding Premenopause Genotype Cell Proliferation Risk Menopause Genes, BRCA2 Genes, erbB-2 Odds Ratio Polymorphism, Single Nucleotide Mutation Apoptosis Signal Transduction Sensitivity and Specificity Algorithms Cell Movement Cell Division Down-Regulation Germ-Line Mutation DNA Methylation Polymorphism, Genetic Gene Amplification Promoter Regions, Genetic Cell Growth Processes Transfection Cell Cycle Up-Regulation RNA Interference Dose-Response Relationship, Drug Gene Expression Parity Gene Silencing Phenotype Cell Survival Genes, Tumor Suppressor Genes, Neoplasm Genes, p53 Epithelial-Mesenchymal Transition Base Sequence Phosphorylation Alleles Heterozygote Diet Drug Synergism Chi-Square Distribution Tumor Microenvironment Transcription, Genetic

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence Registries Algorithms Questionnaires SEER Program Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care35

Survival Analysis Survival Rate Disease-Free Survival Follow-Up Studies Proportional Hazards Models Cohort Studies Prospective Studies Risk Factors Kaplan-Meier Estimate Case-Control Studies Retrospective Studies Treatment Outcome Predictive Value of Tests Multivariate Analysis Risk Risk Assessment Age Factors Incidence Odds Ratio Registries Sensitivity and Specificity Models, Statistical ROC Curve Logistic Models Questionnaires SEER Program Reproducibility of Results Mass Screening Confidence Intervals Clinical Trials as Topic Parity Genetic Testing Age of Onset National Cancer Institute (U.S.)Chi-Square Distribution

Geographicals4

United States China Japan Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prognosis Breast Neoplasms Tumor Markers, Biological Breast Receptors, Estrogen Gene Expression Profiling Neoplasm Staging Survival Analysis Survivors Receptors, Progesterone Receptor, erbB-2 Survival Rate Lymphatic Metastasis Neoplasm Recurrence, Local Disease-Free Survival Follow-Up Studies Carcinoma, Ductal, Breast Gene Expression Regulation, Neoplastic Proportional Hazards Models Cohort Studies Cell Line, Tumor Prospective Studies Neoplasm Invasiveness Breast Diseases Tamoxifen Risk Factors Mammography Neoplasm Metastasis Neoplasms Lung Neoplasms Ovarian Neoplasms Carcinoma Oligonucleotide Array Sequence Analysis Immunohistochemistry Kaplan-Meier Estimate Receptor, Fibroblast Growth Factor, Type 4 Breast Neoplasms, Male Case-Control Studies Antineoplastic Agents, Hormonal Tissue Array Analysis Retrospective Studies Antineoplastic Agents Neoplasm Proteins Treatment Outcome Disease Progression Mastectomy Early Detection of Cancer Reverse Transcriptase Polymerase Chain Reaction Chemotherapy, Adjuvant Genes, BRCA1 Prostatic Neoplasms Adenocarcinoma Postmenopause Predictive Value of Tests Carcinoma, Lobular Multivariate Analysis Time Factors Antineoplastic Combined Chemotherapy Protocols Carcinoma, Intraductal, Noninfiltrating Mice, Nude Genetic Predisposition to Disease MCF-7 Cells Drug Resistance, Neoplasm Tumor Cells, Cultured Colorectal Neoplasms Breast Feeding Estrogen Receptor alpha Premenopause Colonic Neoplasms Genotype Estrogens Cell Proliferation Risk Neoplasms, Hormone-Dependent Mammary Neoplasms, Experimental Breast Self-Examination Risk Assessment Age Factors Menopause RNA, Messenger BRCA2 Protein Genes, BRCA2 BRCA1 Protein Incidence Fibrocystic Breast Disease Aromatase Inhibitors Genes, erbB-2 Odds Ratio Estrogen Antagonists Axilla DNA, Neoplasm Polymorphism, Single Nucleotide Mastectomy, Segmental Mutation Mammary Glands, Human Blotting, Western Apoptosis Xenograft Model Antitumor Assays Registries Bone Neoplasms

No FAQ available that match "breast cancer prognosis"